Medical legalisation efforts in Congress motivate finance company to initiate cannabis drug development programme
It took Ixoreal Biomed 14 years of R&D to develop and refine its KSM-66┬« ashwagandha extract.
Two of the world’s largest drugmakers, Novartis and GlaxoSmithKline (GSK), have agreed a multi-billion dollar asset swap deal
Chief Executive Officer Dr Karsten Wellner discusses the philosophy and values behind Ascendis Health, the home of some of South AfricaÔÇÖs leading health and care brands
Actavis, the second largest generic drugmaker in the world, is to pay $25 billion to purchase Forest Laboratories
After a decade of uncertainty Montreal, Quebec's largest city with a population of 3.8 million and the second largest in Canada, is soon to benefit from a $2.5 billion state of
General Manager, Javier Fuenzalida, discusses the vital contributions ESACHS makes towards Chile’s well-respected health care system
California-based Pearl Therapeutics is to become part of AstraZeneca
Actavis, the US drugs maker, is to buy Dublin-based Warner Chilcott in a deal worth $8.5 billion
From its new, 40,000 square foot facility in the GerjiJakros region, Julphar is able to supply one of Africa’s fastest growing nations with vital pharmaceutical and healthcare p
Award winning UK oxygen concentrator developed for the battlefield could save infant lives
Healthcare delivery in Africa is to benefit from a $10.6 million public-private financing initiative from the Medical Credit Fund (MCF).
The world’s largest food group, Nestle, has announced a deal to develop treatments based on traditional Chinese medicines.
This Edition inlcudes Editorial profiles on Eugal Pipeline, Infrastructure Malta, IVAP, EDM, Shanta Gold, Port of Algeciras and more